Scalable Symptom Monitoring Intervention May Up Asthma-Related QoL in Subgroup of Adults

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 8, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 8, 2025 -- A scalable symptom monitoring intervention increases asthma-related quality of life in adults, according to a study published online April 23 in JAMA Network Open.

Robert S. Rudin, Ph.D., from RAND in Boston, and colleagues examined the effect of a scalable asthma symptom monitoring intervention on asthma outcomes in a randomized clinical trial involving adults with a diagnosis of asthma between July 2020 and March 2023. Patients were categorized into tiers of varying disease activity. Intervention group patients completed weekly symptom questionnaires and viewed educational information. Usual care group patients received general asthma guidance. The primary analysis included 366 patients.

The researchers found that the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) score increased 0.34 and 0.11 in the intervention and usual care groups, respectively, from baseline to completion of the final questionnaire (adjusted difference-in-difference, 0.23); the difference was statistically significant but did not meet the threshold for minimally important change. Relative to the usual care group, intervention subgroups showed positive differences in MiniAQLQ scores, with noteworthy increases among individuals aged 18 to 44 years, those with low baseline patient activation, those with a low baseline MiniAQLQ score, and those with uncontrolled asthma at baseline (adjusted difference-in-differences, 0.40, 0.77, 0.33, and 0.30, respectively). The intervention and usual care groups had a mean of 0.59 and 0.76 nonroutine asthma-related utilization events, respectively.

“Overall, these data suggest that the between-visit symptom monitoring led to an average improvement in asthma quality of life among study patients, although this improvement did not meet the threshold of a minimally important change,” the authors wrote. “However, the intervention showed potential benefits for certain subgroups and may be useful in other chronic diseases in which between-visit symptoms are important.”

Two authors disclosed ties to industry; one reported holding a related patent.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-09 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords